Updated 11 February 2026
Date of assessment: 23 February 2026 to Thursday 12 March.
Kings Den is a residential care home providing accommodation for persons who require nursing or personal care for up to 4 people. The service provides support to people with a learning disability and autistic people. At the time of our inspection there were 4 people using the service supported in one adapted building.
At our last assessment in June 2022, we rated the service requires improvement overall. The provider was previously in breach of 3 legal regulations relating to safe care and treatment, fit and proper persons employed and good governance. At this assessment, improvements had been made and the provider was no longer in breach of these regulations. At this assessment we looked at all 33 quality statements and provided the service with a new overall rating.
We assessed the service against ‘Right support, right care, right culture’ guidance to make judgements about whether the provider guaranteed people with a learning disability and autistic people respect, equality, dignity, choices, independence and good access to local communities that most people take for granted.
During the assessment we visited the service, spoke with people, staff and management. We reviewed people’s care records, risk assessments and medicines records. We also looked at audits, policies and training records.
We identified a concern relating to the environment, where the provider was not compliant with HSE (Health and Safety Executive) guidance. We raised this with the registered manager who took immediate action to resolve the issue.
Staff enabled people to share feedback and ideas, or raise complaints about their care, treatment and support. Staff involved people in decisions about their care and told them what had changed as a result.
Safeguarding procedures were in place. The service learned from accidents, incidents and events. Recruitment processes were now established and operated effectively. People received their medicines as prescribed, and processes for ensuring safe monitoring of medicines were now in place. Governance systems had now been strengthened.